Visfatin/Nampt: An Adipokine with Cardiovascular Impact
Adipose tissue is acknowledged as an endocrine organ that releases bioactive factors termed adipokines. Visfatin was initially identified as a novel adipokine with insulin-mimetic properties in mice. This adipokine was identical to two previously described molecules, namely, pre-B cell colony-enhanc...
Saved in:
Main Authors: | Tania Romacho (Author), Carlos F. Sánchez-Ferrer (Author), Concepción Peiró (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visfatin/PBEF/Nampt: a new cardiovascular target?
by: Concepción ePeiró, et al.
Published: (2010) -
Secretion of One Adipokine Nampt/Visfatin Suppresses the Inflammatory Stress-Induced NF-κB Activity and Affects Nampt-Dependent Cell Viability in Huh-7 Cells
by: Yi-Ching Lin, et al.
Published: (2015) -
Angiotensin-Converting Enzyme Inhibitors and Adipokines: The Role of Visfatin and Apelin in Cardiovascular Disease Management
by: Yaseen Jumaah, et al.
Published: (2023) -
Evaluation of Adipokines: Apelin, Visfatin, and Resistin in Children with Atopic Dermatitis
by: Edyta Machura, et al.
Published: (2013) -
Evaluation of Visceral Adipokines: Omentin, Vaspin, and Visfatin in Patients with Gestational Diabetes Mellitus
by: Mehmet Yilmaz, et al.
Published: (2024)